Patent details
300960 Product Name: Combinatie van daunorubicine en cytarabine
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300960
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP1744764
- Status:
- SPC in force
- Application number:
- 300960
- Procedural language:
- Dutch
- First Applicant Residence Country:
- United States of America (US)
Marketing Authorization
- Marketing Authorization Number:
- EU/1/18/1308
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 27/08/2018
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 11/12/2018
- First Marketing Authorization date:
- 27/08/2018
- Grant date:
- 22/05/2019
- Activation date:
- 22/04/2025
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 13/12/2018
- SPC/SPC Extension Expiration Date:
- 21/04/2030
- Lapsed By Expiration Date:
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 28/08/2025
- Name:
- Jazz Pharmaceuticals Therapeutics, Inc.
- Address:
- 3000 El Camino Real 2 Palo Alto Square, Suite 600, 94306, Palo Alto, CA, United States of America (US)
Historical Applicant/holder
- From:
- 11/12/2018
- To:
- 28/08/2025
- Name:
- Celator Pharmaceuticals, Inc.
- Address:
- 200 PrincetonSouth Corporate Centre, Suite 180, 08628, Ewing, New Jersey, United States of America (US)
Agent
- Name:
- ir. B.Ch. Ledeboer c.s
- From:
- 11/12/2018
- Address:
- V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Journal edition number:
- 36/25
- Publication date:
- 03/09/2025
- Description:
- Changes in the Netherlands Patent Register
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 17/25
- Publication date:
- 23/04/2025
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
- Bulletin Heading:
- SPC
- Journal edition number:
- 22/19
- Publication date:
- 29/05/2019
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
- Bulletin Heading:
- SPC
- Journal edition number:
- 52/18
- Publication date:
- 19/12/2018
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name
- Deed Number:
- RC202501383A
- Date Registered:
- 28/08/2025
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- dr. R.C. van Duijvenbode c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Jazz Pharmaceuticals Therapeutics, Inc.
- Address:
- 3000 El Camino Real 2 Palo Alto Square, Suite 600, 94306, Palo Alto, CA, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 30/04/2026
- Annual Fee Number:
- 22
- Annual Fee Amount:
- 1800 Euro
- Last Annual Payment Date:
- 08/04/2025
- Last Annual Fee Paid Number:
- 21
- Last Annual Fee Paid Amount:
- 1600 Euro
- Payer:
- Arnold & Siedsma BV
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 22/05/2019 | SPC Documents | Certificate SPC | 1 | /8/5/5/2/5/0800352558/docs/300960_0_supplprotectioncertificate20190524101737967.pdf | ||
| 22/05/2019 | Outgoing Correspondence | Decision grant | 1 | /8/5/5/2/5/0800352558/docs/300960_6_outgoingcorrespondence20190524101737857.pdf | ||
| 17/04/2019 | SPC Documents | Annex SPC | 103 | /8/5/5/2/5/0800352558/docs/300960_5_supplprotectioncertificate20210115042943937.pdf | ||
| 17/04/2019 | Incoming Correspondence Paper | Accompanying letter incoming document | 3 | /8/5/5/2/5/0800352558/docs/300960_7_incomingcorrespondencepaper20210319043906916.pdf | ||
| 17/04/2019 | SPC Documents | Annex SPC | 18 | /8/5/5/2/5/0800352558/docs/300960_9_supplprotectioncertificate20210115042944099.pdf | ||
| 17/04/2019 | SPC Documents | Annex SPC | 22 | /8/5/5/2/5/0800352558/docs/300960_10_supplprotectioncertificate20210115042943780.pdf | ||
| 05/02/2019 | Outgoing Correspondence | Letter to applicant | 2 | /8/5/5/2/5/0800352558/docs/300960_8_outgoingcorrespondence20190206104314332.pdf | ||
| 13/12/2018 | Outgoing Correspondence | Confirmation receipt request | 1 | /8/5/5/2/5/0800352558/docs/300960_3_245063l174.pdf | ||
| 11/12/2018 | SPC Documents | Annex SPC | 2 | /8/5/5/2/5/0800352558/docs/300960_1_supplprotectioncertificate20181213012655253.pdf | ||
| 11/12/2018 | SPC Documents | Annex SPC | 13 | /8/5/5/2/5/0800352558/docs/300960_2_supplprotectioncertificate20181213012655354.pdf | ||
| 11/12/2018 | Application Form | First filed application form | 3 | /8/5/5/2/5/0800352558/docs/300960_4_applicationform20181213031926348.pdf | ||
| 11/12/2018 | SPC Documents | SPC Documents | 18 | /8/5/5/2/5/0800352558/docs/300960_11_supplprotectioncertificate20181213012655146.pdf | ||
| 11/12/2018 | SPC Documents | Marketing Authorization SPC | 3 | /8/5/5/2/5/0800352558/docs/300960_12_supplprotectioncertificate20181213012655045.pdf |